Post Marketing Information DHCPL 23/07/2019 Risk of non-melanoma skin cancer associated with use of hydrochlorothiazide DHCPL 03/12/2018 Hydrochlorothiazide: Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) [Sanofi] DHCPL 21/11/2018 Hydrochlorothiazide: Increased risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) DHCPL 14/11/2018 Hydrochlorothiazide: Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet, Film Coated, Hydrochlorothiazide 12.5 mg + Valsartan 80 mg Alexandra Hospital National Healthcare Group Polyclinics National University Hospital National University Polyclinics Sengkang General Hospital Tan Tock Seng Hospital Tablet, Film Coated, Hydrochlorothiazide 12.5 mg + Valsartan 160 mg Alexandra Hospital National Healthcare Group Polyclinics National University Hospital National University Polyclinics Tan Tock Seng Hospital
ORAL Select a brand starting with the letter: C CO-DIOVAN 160/12.5 TABLET [SIN11339P] CO-DIOVAN 160/25 TABLET [SIN12011P] CO-DIOVAN 80/12.5 TABLET [SIN10538P]